Kimberly Elmore

1PUBLICATIONS
3CO-AUTHORS
Injury prevention
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Apr 28, 2025
EDP-323, a First-In-Class, Once-Daily, Oral L-Protein Inhibitor for the Treatment of RSV: Results From a Phase 1 Study in Healthy Adults.

Kimberly Elmore, John DeVincenzo, Michael H J Rhodin

Pageof 1